Dapagliflozin Add-on in Unresectable HCC With Metabolic Syndrome

Clinical trial NCT07729592 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07729592
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)

Start date: 2026-07-01
Primary completion: 2029-07-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.